• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喉保留

Larynx preservation.

机构信息

Head and Neck Department, Centre Oscar Lambret, Lille, France.

出版信息

Curr Opin Oncol. 2012 May;24(3):218-22. doi: 10.1097/CCO.0b013e3283523c95.

DOI:10.1097/CCO.0b013e3283523c95
PMID:22450148
Abstract

PURPOSE OF REVIEW

Organ preservation, in particular larynx preservation, is a major challenge that has been evaluated during the past 3 decades. This review took in consideration the most recently published articles on this topic.

RECENT FINDINGS

There are no new data on this topic but mainly confirming data. Most of the reports underscored that there was still a place for upfront surgery (either partial or total laryngectomy). Nonsurgical approaches are radiotherapy alone or chemotherapy-based protocols with either induction or concomitant chemotherapy added to radiotherapy (with conventional or accelerated fractionation). Different authors underscored that daily practice must follow carefully the selection of patients and monitoring of treatment when applying protocols evaluated in randomized clinical trials.

SUMMARY

Larynx preservation is an undisputable advance in larynx cancer management. For early diseases, either surgery (open or endoscopic) or irradiation may control the disease and preserve the larynx function. For advanced cases, chemotherapy-based protocols have been validated, but the best protocol is still to be defined. Importantly some cases still require upfront total laryngectomy. A multidisciplinary approach for decision making is mandatory, whatever the stage.

摘要

目的综述

在过去的 30 年中,器官保存,特别是喉保存,一直是一个重大挑战。本综述考虑了该主题最近发表的文章。

最近发现

该主题没有新的数据,主要是确认数据。大多数报告强调,仍有必要进行 upfront 手术(部分或全喉切除术)。非手术方法是单独放疗或基于化疗的方案,要么在放疗中加入诱导或伴随化疗(常规或加速分割)。不同的作者强调,在应用随机临床试验评估的方案时,日常实践必须仔细选择患者并监测治疗。

总结

喉保存是喉癌治疗的一个无可争议的进展。对于早期疾病,手术(开放性或内镜性)或放疗都可以控制疾病并保留喉功能。对于晚期病例,已经验证了基于化疗的方案,但最好的方案仍有待确定。重要的是,有些病例仍需要 upfront 全喉切除术。无论分期如何,决策都需要多学科方法。

相似文献

1
Larynx preservation.喉保留
Curr Opin Oncol. 2012 May;24(3):218-22. doi: 10.1097/CCO.0b013e3283523c95.
2
[Induction chemotherapy and larynx preservation: is such practice useful?].[诱导化疗与喉保留:这种做法有用吗?]
Bull Cancer. 2002 Apr;89(4):411-7.
3
Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.喉保留临床试验设计:关键问题与建议——共识小组总结
Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1293-303. doi: 10.1016/j.ijrobp.2008.10.047.
4
Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.诱导化疗在喉保留策略中仍有作用吗?加泰罗尼亚肿瘤研究所对III期喉癌的治疗经验。
Laryngoscope. 2006 Sep;116(9):1651-6. doi: 10.1097/01.mlg.0000231736.08477.47.
5
Combined modality treatment of laryngeal squamous cell carcinoma.喉鳞状细胞癌的综合治疗
Expert Rev Anticancer Ther. 2007 Mar;7(3):331-50. doi: 10.1586/14737140.7.3.331.
6
Larynx preservation and survival trends: should there be concern?喉保留与生存趋势:是否应引起关注?
Head Neck. 2010 Jan;32(1):14-7. doi: 10.1002/hed.21295.
7
Organ preservation therapy for advanced-stage laryngeal carcinoma.晚期喉癌的器官保存治疗。
Otolaryngol Clin North Am. 1997 Feb;30(1):113-30.
8
Larynx preservation: what is the best non-surgical strategy?喉保留:最佳非手术策略是什么?
Crit Rev Oncol Hematol. 2013 Nov;88(2):447-58. doi: 10.1016/j.critrevonc.2013.05.005. Epub 2013 Jun 5.
9
Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.单周期诱导化疗为同步放化疗选择晚期喉癌患者:一种新的治疗模式。
J Clin Oncol. 2006 Feb 1;24(4):593-8. doi: 10.1200/JCO.2005.01.2047. Epub 2005 Dec 27.
10
Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.晚期喉癌器官保留试验的语音和吞咽结果
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1395-9. doi: 10.1016/j.ijrobp.2005.05.004. Epub 2005 Aug 8.

引用本文的文献

1
Chemoradiotherapy but Not Radiotherapy Alone for Larynx Preservation in T3. Considerations from a German Observational Cohort Study.T3期喉癌保喉治疗采用放化疗而非单纯放疗:来自德国一项观察性队列研究的思考
Cancers (Basel). 2021 Jul 8;13(14):3435. doi: 10.3390/cancers13143435.
2
A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal Cancers.一项关于局部晚期喉癌和下咽癌患者喉保留与手术切除对比的10年研究。
Front Oncol. 2020 Oct 15;10:535893. doi: 10.3389/fonc.2020.535893. eCollection 2020.
3
Current Role of Total Laryngectomy in the Era of Organ Preservation.
全喉切除术在器官保留时代的当前作用。
Cancers (Basel). 2020 Mar 3;12(3):584. doi: 10.3390/cancers12030584.
4
Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma.改变模式:喉鳞状细胞癌靶向治疗的潜力
Cancer Biol Med. 2016 Mar;13(1):87-100. doi: 10.28092/j.issn.2095-3941.2016.0010.
5
Early Cellular Response to Radiation in Human Vocal Fold Fibroblasts.人声带成纤维细胞对辐射的早期细胞反应。
Ann Otol Rhinol Laryngol. 2016 May;125(5):425-32. doi: 10.1177/0003489415615140. Epub 2015 Nov 8.
6
Different spectral hounsfield unit curve and high-energy virtual monochromatic image characteristics of squamous cell carcinoma compared with nonossified thyroid cartilage.与未骨化甲状腺软骨相比,鳞状细胞癌的不同光谱亨氏单位曲线及高能虚拟单色图像特征
AJNR Am J Neuroradiol. 2015 Jun;36(6):1194-200. doi: 10.3174/ajnr.A4253. Epub 2015 Mar 5.
7
Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up.联合放化疗与局部微波热疗治疗T3N0期喉癌:一项长期随访的回顾性研究
Acta Otorhinolaryngol Ital. 2014 Jun;34(3):167-73.
8
Function preservation using transoral laser surgery for T2-T3 glottic cancer: oncologic, vocal, and swallowing outcomes.经口激光手术治疗 T2-T3 声门型喉癌的功能保留:肿瘤学、嗓音和吞咽结局。
Eur Arch Otorhinolaryngol. 2013 Aug;270(8):2275-81. doi: 10.1007/s00405-013-2461-9. Epub 2013 Apr 9.
9
Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.可手术治疗的鳞状细胞喉癌中胰岛素样生长因子 1 受体(IGF1R)的表达与生存。
PLoS One. 2013;8(1):e54048. doi: 10.1371/journal.pone.0054048. Epub 2013 Jan 24.